Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Infectious Diseases Society of America (IDSA). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Infectious Diseases Society of America (IDSA) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Exploring Microbiome-Based Therapy

27:55
 
Share
 

Manage episode 400195822 series 103415
Content provided by Infectious Diseases Society of America (IDSA). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Infectious Diseases Society of America (IDSA) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Host Paul Sax, MD, FIDSA, is joined by Libby Hohmann, MD, FIDSA, an ID specialist at Massachusetts General Hospital, director of the Fecal Microbiota Transplant Lab and associate professor of medicine at Harvard Medical School, to discuss the innovative field of microbiome-based therapy, including the latest therapeutics, efficacy in treating COVID-19 and advice on treating patients with C. diff.

  continue reading

233 episodes

Artwork

Exploring Microbiome-Based Therapy

Let's Talk ID

103 subscribers

published

iconShare
 
Manage episode 400195822 series 103415
Content provided by Infectious Diseases Society of America (IDSA). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Infectious Diseases Society of America (IDSA) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Host Paul Sax, MD, FIDSA, is joined by Libby Hohmann, MD, FIDSA, an ID specialist at Massachusetts General Hospital, director of the Fecal Microbiota Transplant Lab and associate professor of medicine at Harvard Medical School, to discuss the innovative field of microbiome-based therapy, including the latest therapeutics, efficacy in treating COVID-19 and advice on treating patients with C. diff.

  continue reading

233 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play